» Articles » PMID: 22194607

Macro Histone H2A1.2 (macroH2A1) Protein Suppresses Mitotic Kinase VRK1 During Interphase

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2011 Dec 24
PMID 22194607
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

VRK1-mediated phosphorylation of histone H3 should be restricted in mitosis for consistent cell cycling, and defects in this process trigger cellular catastrophe. However, an interphasic regulator against VRK1 has not been actually investigated so far. Here, we show that the histone variant macrodomain-containing histone H2A1.2 functions as a suppressor against VRK1 during interphase. The level of macroH2A1.2 was markedly reduced in the mitotic phase, and the macroH2A1.2-mediated inhibition of histone H3 phosphorylation occurred mainly during interphase. We also found direct interaction and binding features between VRK1 and macroH2A1.2 by NMR spectroscopy. Hence, our findings might provide valuable insight into the underlying molecular mechanism regarding an epigenetic regulation of histone H3 during the cell cycle.

Citing Articles

Identification of VRK1 as a Novel Potential Biomarker for Prognosis and Immunotherapy in Hepatocellular Carcinoma.

He X, Zai G, Zhou L, Chen S, Wang G J Inflamm Res. 2024; 17:1671-1683.

PMID: 38504696 PMC: 10948335. DOI: 10.2147/JIR.S452505.


Comprehensively prognostic and immunological analysis of VRK Serine/Threonine Kinase 1 in pan-cancer and identification in hepatocellular carcinoma.

Chen D, Zhou W, Chen J, Wang J Aging (Albany NY). 2023; 15(24):15504-15524.

PMID: 38157278 PMC: 10781469. DOI: 10.18632/aging.205389.


Dissecting the roles of Haspin and VRK1 in histone H3 phosphorylation during mitosis.

Cartwright T, Harris R, Meyer S, Mon A, Watson N, Tan C Sci Rep. 2022; 12(1):11210.

PMID: 35778595 PMC: 9249732. DOI: 10.1038/s41598-022-15339-8.


VRK1 Predicts Poor Prognosis and Promotes Bladder Cancer Growth and Metastasis and .

Wu J, Li T, Ji H, Chen Z, Zhai B Front Pharmacol. 2022; 13:874235.

PMID: 35559251 PMC: 9086458. DOI: 10.3389/fphar.2022.874235.


Dysregulation of Cellular VRK1, BAF, and Innate Immune Signaling by the Vaccinia Virus B12 Pseudokinase.

Linville A, Rico A, Teague H, Binsted L, Smith G, Albarnaz J J Virol. 2022; 96(11):e0039822.

PMID: 35543552 PMC: 9175622. DOI: 10.1128/jvi.00398-22.


References
1.
Nichols R, Wiebe M, Traktman P . The vaccinia-related kinases phosphorylate the N' terminus of BAF, regulating its interaction with DNA and its retention in the nucleus. Mol Biol Cell. 2006; 17(5):2451-64. PMC: 1446082. DOI: 10.1091/mbc.e05-12-1179. View

2.
Park C, Choi B, Jeong M, Kim S, Kim W, Song Y . Protein kinase Cδ regulates vaccinia-related kinase 1 in DNA damage-induced apoptosis. Mol Biol Cell. 2011; 22(8):1398-408. PMC: 3078082. DOI: 10.1091/mbc.E10-08-0717. View

3.
Agelopoulos M, Thanos D . Epigenetic determination of a cell-specific gene expression program by ATF-2 and the histone variant macroH2A. EMBO J. 2006; 25(20):4843-53. PMC: 1618095. DOI: 10.1038/sj.emboj.7601364. View

4.
Sevilla A, Santos C, Barcia R, Vega F, Lazo P . c-Jun phosphorylation by the human vaccinia-related kinase 1 (VRK1) and its cooperation with the N-terminal kinase of c-Jun (JNK). Oncogene. 2004; 23(55):8950-8. DOI: 10.1038/sj.onc.1208015. View

5.
Bernstein E, Muratore-Schroeder T, Diaz R, Chow J, Changolkar L, Shabanowitz J . A phosphorylated subpopulation of the histone variant macroH2A1 is excluded from the inactive X chromosome and enriched during mitosis. Proc Natl Acad Sci U S A. 2008; 105(5):1533-8. PMC: 2234179. DOI: 10.1073/pnas.0711632105. View